Hanamura, Ichiro
Article History
Received: 31 March 2022
Revised: 11 April 2022
Accepted: 11 April 2022
First Online: 9 May 2022
Declarations
:
: The author received honoraria and/or membership on an entity's board of directors, speakers’ bureau, or advisory committees from Celgene, Janssen, Takeda, Ono, Bristol-Myers Squibb (BMS), Novartis, Daiichi Sankyo, Kyowa Kirin, Eisai, Nihon-Shinyaku, Pfizer, AbbVie, Otsuka, Shionogi, Mundi, CSL Behring, and Merck Sharp & Dohme. The author received research funding from BMS, Ono, Kyowa Kirin, Sanofi, Takeda, and Celgene.